HIGHLIGHTS
- who: Weipu Mao from the Department of Urology, School of Medicine, Shanghai Tenth People`s Hospital, Tongji University, No301, Yanchang Road, Jing`an District, Shanghai, P. R. China have published the research work: Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma, in the Journal: (JOURNAL)
- what: The authors also examined the biological functions of SLERCC in RCC.
- how: QRT-PCR analysis of SLERCC expression in 90 pairs of RCC and correspondingly matched normal tissues in the clinical data showed that SLERCC expression was significantly reduced . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.